HYBRID EVENT: You can participate in person at Boston, Massachusetts, USA or Virtually from your home or work.

8th Edition of International Conference on Neurology and Brain Disorders

October 19-21, 2023

October 19 -21, 2023 | Boston, Massachusetts, USA

INBC 2023

Speaker at Neurology and Brain Disorders 2023 - Thomas J Webster
Keynote Presentation (In-Person)
Thomas J Webster, Interstellar Therapeutics, United States

Stem cells have not provided the universal, effective solution to neurological diseases that they were once thought to provide. In particular, maintaining stem cell viability during and after implantation into the brain has proved problematic. The use of enzymes (such as trypsin) [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Ken Ware
Keynote Presentation (Virtual)
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia

Did the patient genetically inherit their complex psychophysical pathological condition/s or are they simply adopting and/or mirroring other members of their family who have the complex psychophysical condition that the patient is exhibiting? Over several decades it has been f [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Marina Martinez Vargas
Oral Presentation (In-Person)
Marina Martinez Vargas, Baylor College of Medicine, United States

Von Willebrand factor (VWF) is a multimeric protein that mediates thromboinflammation and has been linked to traumatic brain injury (TBI), specifically in the pathogenesis of early brain injury. Activated endothelium secretes VWF multimers as long hyperadhesive strings. During TB [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Teris Cheung
Oral Presentation (In-Person)
Teris Cheung, The Hong Kong Polytechnic University, Hong Kong

Transcranial pulse stimulation (TPS) has been proven effective to improve cognition, memory and depressive symptoms on Alzheimer’s disease, but supporting evidence on other neurological diseases or neuropsychiatric disorders remains limited. We aimed to investigate the effe [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Teris Cheung
Oral Presentation (In-Person)
Teris Cheung, The Hong Kong Polytechnic University, Hong Kong

Insomnia is a common health problem in the general population. There are different ways to improve sleeping habits and quality of sleep, however; there is no clinical trial using transdermal neurostimulation to treat individuals with symptoms of insomnia in Asia. This gave us the [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Eshani Mahajan
Oral Presentation (In-Person)
Eshani Mahajan, Postgraduate Institute of Medical Education and Research-PIGMER, India

IRL-1620 is a chemical entity that have neuroprotective activity as it increases growth factors VEGF and NGF. The Present study hypothesis is to evaluate the effect of IRL-1620 on Aß induced memory loss in the rat model of Alzheimer’s disease. We have taken 58 males a [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Farsana  F J
Oral Presentation (In-Person)
Farsana F J, Digital University Kerala, India

Oxygen extraction fraction (OEF) is a physiological biomarker reflecting the percentage of oxygen extracted from the blood supply, which is directly associated with cerebral oxygen metabolism. It can also provide information about the relative deficiencies in cerebral blood suppl [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Nikita Diwan
Oral Presentation (In-Person)
Nikita Diwan, King Georges's Medical University, India

Hyponatremia has been reported in various central nervous system infections like tuberculous meningitis and found to be associated with poor outcome. So far, no study has been conducted on hyponatremia in acute encephalitis syndrome (AES) in children. This study was planned to st [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Engy Asem Ashaat
Oral Presentation (In-Person)
Engy Asem Ashaat, National Research Centre, Egypt

Alopecia intellectual disability syndromes 4 (APMR4) is a very rare autosomal recessive condition caused by a mutation in  the LSS gene present on chromosome 21. This syndrome has a clinical heterogeneity mainly exhibited with variable degrees of intellectual disability (ID) [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Manish kumar
Oral Presentation (In-Person)
Manish kumar, CSIR-IGIB, India

Spinocerebellar ataxia type-12 (SCA12) is a neurodegenerative disease and one of the most prominent SCA-subtype in India that exhibits a unique progressive tremor/ataxia syndrome induced by triplet (CAG) repeat expansion in 5’ UTR region of PPP2R2B. So far, no study has bee [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Stephen Onyancha Kamanda
Oral Presentation (In-Person)
Stephen Onyancha Kamanda, Kenyatta National Hospital, Kenya

Scoliosis is commonly described as a 3D spinal deformity resulting in a curvature of 10 degress or more with a rotational spin. All the bones in the body have three cells that work together for the proper growth of the bone: The osteocyte,cell that coordinates the osseous work [....] » Read More

Speaker at Neurology and Brain Disorders 2023 -  Afsaneh Nikjooy
Oral Presentation (In-Person)
Afsaneh Nikjooy, Iran university of medical sciences, Iran (Islamic Republic of)

Background: Dyssynergic defecation (DD) is a major cause of chronic functional constipation. Patients with DD have greater psychological distress and impaired health-related quality of life compared with the general  population. This study aimed to evaluate the effectivene [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Mohamed Fathi Al Gharyani
Oral Presentation (In-Person)
Mohamed Fathi Al Gharyani, Benghazi Medical Center, Libyan Arab Jamahiriya

Background: Since the COVID-19 pandemic, many studies have reported severe neurologic effects of the infection on the brain. Intracerebral haemorrhage (ICH) is a particular pathology that can result in these devastating neurologic effects and affected patients are more likely to [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Nahom
Oral Presentation (In-Person)
Nahom, FelgeHiwot Referal Hospital, Ethiopia

The COVID-19 pandemic has caused an unprecedented impact on global health, affecting millions of people worldwide. In effect to tackling the devastating outcomes of the disease, the development of vaccines was the primary focus of health researchers worldwide. Thus, a few brands [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Mehdi Sheikhi
Oral Presentation (In-Person)
Mehdi Sheikhi, AJA University of Medical Sciences, Iran (Islamic Republic of)

Stroke is a leading cause of morbidity and second cause of mortality worldwide. Early participation in rehabilitation treatments such as neurostimulant drugs showed to be beneficial. Amantadine usually used as Parkinson disease treatment, is prescribed in patients with traumatic [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Navdeep Kaur
Oral Presentation (In-Person)
Navdeep Kaur, Cleveland Clinic Foundation, United States

Stroke is the second most common cause of cognitive impairment and dementia. Vascular dementia (VaD), a cognitive impairment following a stroke is common and substantially affects the quality of life. We recently demonstrated via gut microbe transplant studies that the gut microb [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Eva Maria Gonzalez Diaz
Oral Presentation (In-Person)
Eva Maria Gonzalez Diaz, Cruces University Hospital, Spain

Objective: The clinical benefit of mechanical thrombectomy(MT) in acute ischemic stroke treatment, is correlated to the degree of reperfusion achieved. The First Pass Effect (FPE) is defined as complete/near revascularisation of the large-vessel occlusion [modified Thrombolysis [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Mikaela Atkins
Poster Presentation (In-Person)
Mikaela Atkins, Arizona State University, United States

At one of the largest hospitals in Arizona, who care for individuals suffering from neurological diseases and houses a Joint Commission Comprehensive Stroke Center, the Comprehensive Stroke Program Quality Team has been working in conjunction with an Arizona State University Doct [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Carmen Vogt
Poster Presentation (In-Person)
Carmen Vogt, University of Nebraska Medical Center, United States

Restless Legs Syndrome (RLS) is associated with uncomfortable sensations in limbs that result in a sudden urge to move. The underlying etiology is unknown but is thought to be influenced by genetics, pregnancy, iron deficiency, and alterations in nerve hyperexcitability or inhibi [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Aliaa Mousa
Poster Presentation (In-Person)
Aliaa Mousa, Capital Health, United States

Introduction In the literature, there are not so many cases that connected Atherosclerosis to MMDandit hasn’t been assured by pathological studies as well. Moya Moya disease is a uniquecerebrovascular disease characterized by progressive large intracranial artery narrowing [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Amy Zhou
Poster Presentation (In-Person)
Amy Zhou, University of Saskatchewan, Canada

Introduction Chronic subdural hematoma (cSDH) is one of the most encountered conditions seen in neurosurgery. Although mainstay treatment of cSDH has been burr hole drainage, no consensus yet exists on optimal anesthesia technique for surgical treatment. Currently, the decision t [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Ayako Fukuda
Poster Presentation (In-Person)
Ayako Fukuda, Dokkyo University, Japan

There are three types of Japanese characters: hiragana, katakana and kanji. Of these, hiragana is said to be easier to be acquired because of its regularity and one-to-one correspondence between letters and sounds (Uno et al., 2009). Therefore, early identification and support of [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Divya Goel
Poster Presentation (In-Person)
Divya Goel, Jamia Hamdard, India

Glioblastoma (GBM) is a fatal brain cancer in adults with ineffective existing treatment methods. Cell adhesion molecules (CAMs) are proteins that are expressed on the surface of cells and enable them to communicate and interact with one another and the surrounding environment. I [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Neetika Sharma
Poster Presentation (In-Person)
Neetika Sharma, PGIMER, India

59 yrs old male presented with 11 months history of ataxia followed by 3 months history of bilateral hand action tremors. 9 month into illness he started to have cognitive decline followed by myoclonic jerks . He also had fragmented sleep with decreased total sleep duration. He h [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Duaa Awad Ahmed Abdelsalam
Poster Presentation (In-Person)
Duaa Awad Ahmed Abdelsalam, University of Khartoum, Sudan

Motor Nerve conduction study is one of the electrophysiological tests performed to evaluate electrical conduction of motor nerves. Many studies involved nerve conduction velocity of peripheral nerves, but only few addressed this issue in relation to handedness with lots of contro [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Juan Solano
Poster Presentation (In-Person)
Juan Solano, University of Antioquia, Colombia

Introduction: A significant number of patients with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) does not fulfill electrodiagnostic demyelination criteria. Evidence suggests that TST may increase the sensitivity of this electrodiagnostic studies by detecting [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - David Joseph Sperbeck
Keynote Presentation (Virtual)
David Joseph Sperbeck, Private practice, United States

Recovery from brain trauma is in part dependent upon the brain’s ability to adapt to new and challenging experiences.  The brain’s capacity to structurally and functionally reorganize nerve cells and spontaneously develop new neuronal networks defines neuroplasti [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Rocco Gennaro
Keynote Presentation (Virtual)
Rocco Gennaro, University of Southern Indiana, United States

In this talk I first review several different notions of the “unity of consciousness” such as subject unity, object unity, spatial unity, and perhaps most common “phenomenal unity” which is the general notion that, from the first-person point of view, we e [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Brandon Lucke Wold
Oral Presentation (Virtual)
Brandon Lucke Wold, University of Florida, United States

Subarachnoid Hemorrhage (SAH) continues to be a leading cause of morbidity and mortality, with cerebral vasospasm as a common etiology of worse clinical progression. The purpose of this study was to evaluate and review the current literature concerning the effective treatment of [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Chathura Siriwardhana
Oral Presentation (Virtual)
Chathura Siriwardhana, University of Hawaii, United States

Background: There is an expanding body of literature implicating heart disease and stroke as a risk factor for Alzheimer disease (AD), highlighting significant pathways. Hawaii state has the most diverse ethnic population in the US and there exists significant racial health dis [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Swetha Ravi
Oral Presentation (Virtual)
Swetha Ravi, Michigan State University, United States

In temporal lobe epilepsy, the ability of the dentate gyrus to limit excitatory cortical input to the hippocampus breaks down, leading to seizures. The dentate gyrus is also thought to help discriminate between similar memories by performing pattern separation, but whether epilep [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Anne Dorothee Rosch
Oral Presentation (Virtual)
Anne Dorothee Rosch, University of Edinburgh, United Kingdom

Background:  Parkinson´s Disease (PD) is a progressive neurodegenerative disease manifesting itself in motor and nonmotor symptoms. With disease progression, cognitive deficits ranging from mild cognitive impairment (MCI) to dementia (Galtier et al., 2016) as well as [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Alexis Tang
Oral Presentation (Virtual)
Alexis Tang, University of Edinburgh, United Kingdom

Endovascular coiling (EC) has been identified in systematic reviews and meta-analyses to produce more favourable clinical outcomes in comparison to neurosurgical clipping (NC) when surgically treating a subarachnoid haemorrhage from a ruptured aneurysm. Cost-effectiveness analyse [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Georgios Matis
Oral Presentation (Virtual)
Georgios Matis, University Cologne Hospital, Germany

Ziconotide is a synthetic, water-soluble cone snail venom-derived peptide with a molecular weight of 2,639 Daltons. It is a nonopioid analgesic that selectively binds to N-type voltage-sensitive calcium channels on primary nociceptive afferent nerves in the dorsal horn of the spi [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Ravariu Cristian
Oral Presentation (Virtual)
Ravariu Cristian, Universitatea Politehnica Bucuresti, Romania

The human body tumour lesions are almost ordinary events in its life. Almost every people has moles. The moles are in fact small tumours, which normally doesn’t grow but in certain condition, triggered say by mechanical or radioactive events may become to have an uncontroll [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Lama Saad El Din Mahmoud
Oral Presentation (Virtual)
Lama Saad El Din Mahmoud, October 6 University, Egypt

Background: People with neglect suffer from various spatial deficits in several modalities, which in many cases impair everyday functioning. Virtual reality (VR) is a form of interaction between humans and computers in which a real or imaginary environment is simulated. Users in [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Ammar Aljabri
Oral Presentation (Virtual)
Ammar Aljabri, King Saud Bin Abdulaziz University for Health and Sciences, Saudi Arabia

Introduction: Mild Traumatic Brain Injury (mTBI) or concussion is a common yet undermanaged and underreported condition. This systematic review and meta-analysis aim to determine the efficacy of Vestibular Rehabilitation Therapy (VRT) as a treatment option for mTBI. Methods: [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Seham Azzam
Poster Presentation (Virtual)
Seham Azzam, TTUHSC School of Medicine, United States

Alzheimer’s disease (AD) is a neurodegenerative disease that causes cognitive impairment, characterized by progressive cognitive decline, memory loss, and neuronal death in the cerebral cortex, hippocampus, and other brain regions. Hallmarks of its pathology are amyloid bet [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Sushanta Paudel
Oral Presentation (Virtual)
Sushanta Paudel, Nepalese Army Institute of Health Sciences, Nepal

Background and purpose: SWI can help in the diagnosis of thrombus within the vessel in acute ischemic stroke (AIS) known as susceptibility vessel sign (SVS) and detection of SVS within the vessel can predict treatment modality and outcome. In this study, the purpose is to correl [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Deepa Khanal
Oral Presentation (Virtual)
Deepa Khanal, Manipal College of Medical Sciences, Nepal

Introduction: We present a case of pseudoaneurysm of the facial artery after tonsillectomy managed with successful endovascular coiling. Presentation of Case: 41-year-old lady presented with a history of throat pain and 3 episodes of hematemesis on the 3rd, 4th, and 7th post [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Rachel Johansson
Poster Presentation (Virtual)
Rachel Johansson, UC Davis School of Medicine, United States

Introduction: Infantile Neuronal Ceroid Lipofuscinosis (INCL, also known as CLN1 Batten Disease, or CLN1) is a rare, devastating neurodegenerative disease affecting infants and children.  CLN1 is caused by mutations in the CLN1 gene, which encodes the enzyme palmitoyl-prote [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - David Zeng
Poster Presentation (Virtual)
David Zeng, Johns Hopkins University, United States

Previous work in humanized mouse models of human immunodeficiency virus type-1 (HIV-1) has demonstrated that knocking down the matricellular protein Osteopontin (OPN) in vivo leads to a robust increase in the expression of proinflammatory markers TSPO and AIF-1, suggesting that O [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Kaviya Devaraja
Poster Presentation (Virtual)
Kaviya Devaraja, University of Toronto, Canada

Glioblastoma (GBM) is a fatal brain cancer in adults with ineffective existing treatment methods. Cell adhesion molecules (CAMs) are proteins that are expressed on the surface of cells and enable them to communicate and interact with one another and the surrounding environment. I [....] » Read More

Speaker at Neurology and Brain Disorders 2023 -  Daniel Clayman
Poster Presentation (Virtual)
Daniel Clayman, University of Nottingham, United Kingdom

M80T mutation of triose phosphate isomerase (TPI) presents one potential contributory pathway for developing Alzheimer’s disease (AD). M80T effects the triose phosphate isomerase (TPI) enzyme activity within the glycolysis pathways producing enhanced levels of methylglyoxal [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Andre Augusto Ceballos Melo
Poster Presentation (Virtual)
Andre Augusto Ceballos Melo, Hospital Sao Francisco, Brazil

Design to facilitate the recognition of congruent prosthetic movements, context-to-motion translations guided by image, verbal prompt, users nonverbal communication as facial expressions, gestures, paralinguistics, scene context and object recognition contributes to this process& [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Chen Xuemei
Poster Presentation (Virtual)
Chen Xuemei, Chengdu Fourth People's Hospital, China

Studies have shown differences in neuropsychiatric symptoms (NPSs) of Alzheimer’s disease?AD? between the males and females. However, we do not know whether this difference is influenced by disease severity. Method:  Patients with AD who visited the Memory Cl [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Huicong Wang
Poster Presentation (Virtual)
Huicong Wang, Capital Medical University, China

Objective: Generalized anxiety disorder (GAD) is a typical multisystem disease characterized by decreased activity in the left dorsolateral prefrontal cortex (DLPFC). Transcranial near-infrared stimulation (tNIRS) was used to stimulate the left DLPFC to relieve anxiety, and tran [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Sushanta Paudel
Poster Presentation (Virtual)
Sushanta Paudel, Nepalese Army Institute of Health Sciences, Nepal

Introduction: We present a case of chronic subdural hematoma refractory to burr hole surgery treated successfully with middle meningeal artery embolization. Presentation of Case: 61-year-old gentleman presented with a history of headaches and single episodes of vomiting. Ne [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Mohammad Aadil Qamar
Poster Presentation (Virtual)
Mohammad Aadil Qamar, Ziauddin University, Pakistan

Background: Intramedullary spinal cord ependymomas (IMSCE) are rare tumors that mostly occur in adult patients. Management strategies and related outcomes are heterogeneously reported across the literature, demanding a comprehensive analysis to standardize guidelines. We system [....] » Read More

Watsapp